The Latest in Multiple Sclerosis

Clinical Neurology News

Siponimod trial ‘first’ to show delayed disability in secondary progressive MS

March 22, 2018

Multiple Sclerosis

Clinical Neurology News

MRI finds PML in some natalizumab-treated patients despite negative CSF, no symptoms

March 20, 2018

Multiple Sclerosis

Clinical Neurology News

The case for being open-minded about medical marijuana

March 9, 2018

Neurology Reviews

MS Medication Withdrawn Because of Safety Concerns

March 6, 2018

Multiple Sclerosis

Clinical Neurology News

Alemtuzumab-induced autoimmunity: getting closer to answers

March 6, 2018

Multiple Sclerosis

Clinical Neurology News

MS medication withdrawn because of safety concerns

March 2, 2018

Multiple Sclerosis

Neurology Reviews

Does Vitamin D Level Affect Progressive MS?

March 1, 2018

Multiple Sclerosis

Clinical Neurology News

High dose of novel compound for relapsing-remitting MS shows promise

March 1, 2018

Multiple Sclerosis

Neurology Reviews

How Are Newer DMTs Used in Pediatric MS?

February 28, 2018

Neurology Reviews

Can Online Patient Journals Improve MS Care?

February 28, 2018

Multiple Sclerosis

Neurology Reviews

Health Care Use May Elucidate MS Prodrome

February 28, 2018

Multiple Sclerosis

Clinical Neurology News

Researchers find predictors of worse MS outcomes in post hoc study of three trials

February 28, 2018

Multiple Sclerosis

Neurology Reviews

ECTRIMS and EAN Publish Recommendations for Treating MS

February 27, 2018

Multiple Sclerosis

Clinical Neurology News

Fingolimod switch from an injectable linked to improved outcomes in relapsing MS

February 26, 2018

Multiple Sclerosis

Clinical Neurology News

Extended-interval dosing of natalizumab linked to lower risk of PML

February 22, 2018

Multiple Sclerosis